[The anti-proliferative and anti-inflammatory mechanisms of JAK1 inhibitor SHR0302 versus Ruxolitinib in SET2 cell line and primary cells].
Zhonghua Xue Ye Xue Za Zhi
; 40(12): 1003-1007, 2019 Dec 14.
Article
in Zh
| MEDLINE
| ID: mdl-32023730
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cell Proliferation
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2019
Type:
Article
Affiliation country:
China